Bioceltix begins the next phase of research

We made the next important step on the way to the registration of our drug candidates in the European Medicines Agency. The next phase of ... More

Increasing the company’s share capital

In connection with the issue of series G shares, on April 23, 2021, an increase in the share capital was registered. All formalities related to ... More